HISTOGEN INC (HSTO)

Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering

Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering

Histogen has filed for voluntary Chapt. 11 protection to maximize share offering...

Histogen Announces Second Adjournment of Special Meeting of Stockholders

Histogen Announces Second Adjournment of Special Meeting of Stockholders

Meeting Adjourned for a Final Time to January 4, 2024 at 8:00 a.m. PTPotential Estimated Cash Distribution to Shareholders of $0.30 to $0.41 if Dissolution...

Histogen Announces Adjournment of Special Meeting of Stockholders

Meeting Adjourned to December 14, 2023 at 8:00 a.m. PT

Histogen Announces Adjournment of Special Meeting of Stockholders

Meeting Adjourned to December 14, 2023 at 8:00 a.m. PT...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with a breakdown of the biggest pre-market stock movers that traders will want to watch on Thursday!

Biotech firm Histogen to wind down after failing to raise capital (NASDAQ:HSTO)

Immune-focused biotech firm Histogen (HSTO) said on Monday that it had decided to liquidate after failing to find any viable strategic alternatives. Shares of HSTO fell 4.1% in...

Histogen Announces Board Approval of Complete Liquidation and Dissolution

Histogen Announces Board Approval of Complete Liquidation and Dissolution

SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), today announced that its Board of Directors, after extensive consideration of...

Histogen plans to commence strategic alternatives process (NASDAQ:HSTO)

Therapeutics company Histogen (HSTO) said on Monday that it has completed a review of its business, and plans to commence a process to explore strategic alternatives.

Histogen to Explore Strategic Alternatives

Histogen to Explore Strategic Alternatives

SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are a hot topic with traders on Thursday as we go over the shares seeing the biggest movements this morning.

Histogen Reports First Quarter 2023 Results and Provides Business Update

Histogen Reports First Quarter 2023 Results and Provides Business Update

Received FDA Clearance of IND Application for Emricasan for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Emricasan...

Histogen Announces Online Publication in the Journal of Investigative Dermatology

Histogen Announces Online Publication in the Journal of Investigative Dermatology

Emricasan Treatment has Therapeutic Effect Against Bacterial Skin Infection in Mice Pipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for...